de
novo
pyrimidin
biosynthesi
key
metabol
pathway
involv
multipl
biosynthet
process
identifi
origin
seri
deriv
new
class
pyrimidin
biosynthesi
inhibitor
form
two
edgefus
polycycl
moieti
show
identifi
compound
exhibit
broadspectrum
antivir
activ
immunostimulatori
properti
line
recent
report
link
de
novo
pyrimidin
biosynthesi
innat
defens
mechan
virus
importantli
establish
pyrimidin
depriv
amplifi
product
type
type
iii
interferon
cell
stimul
retino
acidinduc
gene
rigi
ligand
altogeth
result
expand
current
panel
pyrimidin
biosynthesi
inhibitor
illustr
product
antivir
interferon
tightli
coupl
metabol
pathway
function
structur
similar
new
chemic
seri
dicoumarol
report
inhibit
pyrimidin
biosynthesi
dihydroorot
dehydrogenas
dhodh
step
discuss
keyword
antivir
agent
innat
immun
interferon
pyrimidin
metabol
p
yrimidin
nucleosid
includ
uridin
cytidin
thymidin
paramount
precursor
dna
rna
synthesi
also
play
pivot
role
intermedi
synthesi
membran
glycerophospholipid
glycosyl
protein
glycogen
udp
triphosph
also
wellknown
extracellular
mediat
signal
membran
receptor
altogeth
make
pyrimidin
nucleosid
essenti
cellular
metabol
cell
reli
three
sourc
fulfil
need
pyrimidin
first
socal
salvag
pathway
recycl
pyrimidin
nucleobas
nucleosid
produc
degrad
rna
dna
molecul
addit
cell
often
express
passiv
activ
transmembran
transport
enabl
uptak
pyrimidin
particular
uridin
extracellular
bodi
fluid
final
de
novo
biosynthesi
pathway
allow
product
pyrimidin
glutamin
aspart
bicarbon
essenti
prolifer
cell
meet
larg
demand
nucleotid
precursor
contrari
salvag
pathway
combin
pyrimidin
absorpt
extracellular
pool
usual
suffici
satisfi
need
nondivid
cell
multifunct
protein
call
cad
catalyz
initi
step
de
novo
pyrimidin
biosynthesi
physic
link
three
enzym
carbamoylphosph
synthetas
cpsase
aspart
transcarbamylas
atcas
dihydroorotas
dhoas
fourth
enzymat
step
catalyz
dihydroorot
dehydrogenas
dhodh
bound
inner
membran
mitochondria
convert
dihydroorot
dho
orot
final
multifunct
ump
synthas
use
orot
produc
ump
common
precursor
pyrimidin
nucleosid
recent
shown
compound
inhibit
de
novo
pyrimidin
biosynthesi
pathway
exhibit
potent
broadspectrum
antivir
activ
inde
sever
screen
campaign
antivir
molecul
led
identif
either
cad
dhodh
inhibitor
molecul
found
effici
block
vitro
replic
mani
virus
includ
dna
rna
virus
presenc
pyrimidin
biosynthesi
inhibitor
cellular
pool
pyrimidin
collaps
lack
pyrimidin
usual
consid
directli
respons
inhibit
viral
growth
howev
also
report
inhibit
de
novo
pyrimidin
biosynthesi
stimul
innat
immun
respons
particular
transcript
interferonstimul
gene
isg
independ
interferon
ifn
canon
jakstat
pathway
addit
antivir
activ
pyrimidin
biosynthesi
inhibitor
found
strictli
depend
cellular
gene
transcript
nuclear
export
machineri
requir
interferon
regulatori
factor
key
transcript
factor
drive
express
antivir
gene
includ
isg
recent
shown
pyrimidin
biosynthesi
inhibitor
could
increas
express
retino
acidinduc
gene
rigi
cytoplasm
sensor
induc
express
innat
immun
gene
ifn
respons
rna
viru
infect
altogeth
differ
report
support
key
role
innat
immun
respons
antivir
activ
compound
inhibit
de
novo
pyrimidin
biosynthesi
pathway
howev
mechan
link
intracellular
pool
pyrimidin
innat
immun
respons
remain
character
describ
novel
seri
deriv
inhibit
de
novo
pyrimidin
biosynthesi
lead
molecul
seri
call
isol
screen
campaign
previous
describ
aim
identifi
stimul
antivir
gene
phenotyp
assay
use
base
human
cell
transient
transfect
luciferas
report
gene
control
five
interferonstimul
respons
element
isr
regulatori
element
present
promot
sequenc
isg
bind
transcript
factor
activ
type
interferonstimul
virusinfect
cell
irf
therefor
expect
compound
induc
isreluciferas
construct
would
also
stimul
express
endogen
isg
exhibit
potent
broadspectrum
antivir
activ
phenotyp
assay
use
screen
total
chemic
compound
capac
stimul
isreluciferas
express
two
compound
chemic
librari
institut
curi
final
select
studi
includ
alreadi
describ
novel
term
structur
activ
interestingli
function
studi
chemic
seri
led
us
show
first
time
cell
transfect
rigi
ligand
mimick
viral
infect
product
type
interferon
ifni
ifniii
strongli
boost
de
novo
pyrimidin
biosynthesi
block
new
observ
unravel
mechan
cell
modul
commun
neighbor
cell
function
metabol
statu
isreluciferaseinduc
antivir
compound
first
select
chemic
screen
compar
test
molecul
significantli
stimul
express
isreluciferas
report
plasmid
transient
transfect
cell
induct
initi
screen
correspond
novel
chemic
seri
never
report
fig
differ
previous
identifi
screen
although
part
molecul
exhibit
similar
fig
confirm
activ
compound
test
doserespons
experi
cell
report
cell
line
deriv
human
cell
stabl
transfect
isreluciferas
report
gene
shown
fig
increas
luciferas
express
observ
upon
treatment
slightli
inferior
result
obtain
similar
rang
howev
weak
induc
isreluciferas
report
gene
compar
recombin
beta
interferon
fig
nevertheless
decid
character
molecul
evalu
antivir
activ
secondari
assay
first
cell
infect
recombin
strain
measl
viru
mv
express
luciferas
report
viral
replic
mvluc
treat
increas
concentr
h
shown
fig
effici
inhibit
mv
growth
assess
decreas
level
luciferas
activ
cultur
halfmaxim
inhibitori
concentr
ic
mean
standard
deviat
sd
estim
assay
tabl
inhibit
mvluc
persist
h
postinfect
partial
lost
h
limit
highest
concentr
suggest
viru
progress
overcam
antivir
effect
see
fig
supplement
materi
also
show
reduc
log
product
infecti
mv
particl
cell
cultur
determin
viru
titrat
h
postinfect
fig
besid
compound
show
limit
cytotox
concentr
fig
determin
quantif
number
live
cell
versu
dimethyl
sulfoxid
dmso
treat
well
h
cultur
condit
cytotox
concentr
cc
molecul
mean
sd
estim
howev
kinet
studi
show
essenti
inhibit
cellular
prolifer
rather
kill
cell
concentr
inde
number
viabl
cell
increas
less
rapidli
cultur
collaps
initi
number
cell
seed
h
fig
furthermor
fraction
dead
cell
cultur
increas
h
cultur
alway
remain
presenc
absenc
assess
flow
cytometri
analysi
live
dead
fixabl
green
dead
cell
stain
kit
data
shown
antivir
activ
test
two
rna
virus
chikungunya
viru
chikv
human
coronaviru
cell
infect
chikv
treat
dmso
alon
h
cell
immunostain
express
chikv
glycoprotein
shown
fig
effici
suppress
chikv
replic
cell
inhibit
also
confirm
infect
cell
recombin
strain
chikv
express
renilla
luciferas
report
viral
growth
fig
mean
sd
ic
similarli
found
inhibit
growth
human
cell
fig
also
show
reduc
cytopath
effect
assess
quantifi
number
viabl
cell
infect
cultur
fig
altogeth
demonstr
activ
differ
negativestrand
mv
positivestrand
chikv
rna
virus
also
inhibit
cellular
prolifer
structureact
analysi
analog
character
structur
featur
account
activ
first
decid
separ
two
enantiom
racem
mixtur
could
differ
antivir
potenc
thu
enantiom
separ
chiral
chromatographi
test
cell
infect
mvluc
interestingli
one
two
enantiom
exhibit
antivir
potenc
fig
altogeth
demonstr
spatial
requir
respect
connect
indol
moieti
identifi
chemic
featur
account
potenc
select
potent
molecul
set
structur
analog
synthes
see
supplement
materi
antivir
potenc
compound
test
cell
infect
mvluc
correspond
ic
report
tabl
fig
interestingli
addit
halogen
group
methyl
group
ethyl
group
posit
increas
antivir
potenc
higher
tabl
control
shown
inhibit
mv
fig
tabl
also
chikv
fig
ic
replic
increas
potenc
compar
fig
highli
potent
analog
halogen
group
methyl
group
posit
modifi
posit
tabl
addit
methyl
group
posit
show
major
effect
antivir
potenc
contrast
compound
modifi
indol
moieti
much
less
potent
suggest
part
molecul
essenti
tabl
also
test
analog
without
nitro
group
furan
ring
fig
respect
although
show
compar
antivir
potenc
much
less
potent
decreas
besid
open
furan
ring
led
loss
antivir
potenc
support
role
play
part
molecul
fig
structur
modif
test
show
benefit
abrog
antivir
potenc
fig
furthermor
replac
indol
moieti
group
group
previous
describ
refer
greatli
decreas
antivir
activ
comparison
fig
altogeth
establish
structureact
relationship
chemic
seri
analog
potent
initi
hit
identifi
inhibitor
pyrimidin
biosynthesi
mention
select
screen
campaign
togeth
compound
subsequ
character
inhibitor
de
novo
pyrimidin
biosynthesi
although
activ
analog
chemic
unrel
similar
antivir
properti
capac
induc
isreluciferas
report
gene
suggest
similar
mode
action
thu
determin
whether
one
potent
analog
show
better
select
index
could
inhibit
de
novo
pyrimidin
biosynthesi
like
address
question
cell
treat
dmso
alon
nucleosid
level
cellular
extract
determin
highperform
liquid
chromatographi
hplc
spectrophotometri
analysi
shown
fig
uridin
u
cytidin
c
level
collaps
cell
wherea
purin
level
g
unaffect
demonstr
interfer
pyrimidin
metabol
homeostasi
multipl
function
uridin
also
requir
synthes
udpsugar
complex
essenti
protein
glycosyl
thu
determin
whether
could
also
alter
intracellular
level
udpgalactos
udpgal
udp
nacetylgalactosamin
udpgalnac
udpgal
collaps
cell
predict
surprisingli
udpgalnac
maintain
high
level
suggest
specif
mechan
help
secur
intracellular
concentr
metabolit
fig
determin
lack
pyrimidin
nucleosid
cell
account
antivir
potenc
compound
thu
cell
infect
mvluc
cultur
medium
supplement
either
uridin
precursor
pyrimidin
nucleosid
biosynthesi
includ
dihydroorot
dho
orot
fig
uridin
orot
found
restor
viral
replic
cell
assess
luciferas
express
wherea
dho
show
effect
establish
low
level
pyrimidin
nucleosid
account
inhibit
viral
growth
cell
furthermor
fact
orot
dho
could
revert
antivir
effect
suggest
dhodh
fourth
enzym
pyrimidin
biosynthesi
convert
dho
orot
target
fig
line
previou
report
includ
show
dhodh
target
numer
broadspectrum
antivir
compound
investig
potenti
interact
innat
antivir
respons
line
previou
report
show
inhibitor
de
novo
pyrimidin
biosynthesi
stimul
express
isg
first
confirm
induc
isreluciferas
gene
cell
like
wherea
chemic
analog
inhibit
mv
replic
tabl
antimicrobi
agent
chemotherapi
determin
expect
could
also
amplifi
cellular
respons
synthet
ligand
rigi
mimic
viral
nucleic
acid
rna
virus
report
cell
transfect
low
dose
short
synthet
rna
molecul
ssrna
prime
innat
immun
respons
without
reach
satur
cultur
dmso
alon
h
shown
fig
amplifi
isreluciferas
express
respons
ssrna
transfect
contrast
effect
cellular
respons
toward
ssrna
fig
also
test
effect
isreluciferas
induct
viru
thu
cell
infect
mv
differ
multipl
infect
moi
incub
h
let
viru
trigger
innat
immun
respons
dmso
alon
ad
addit
incub
period
h
shown
fig
effici
boost
cellular
respons
mv
infect
assess
increas
express
level
isreluciferas
report
gene
final
determin
could
also
boost
express
ifn
respons
ssrna
someth
investig
address
question
supernat
cell
cultur
transfect
ssrna
treat
dmso
alon
h
collect
dilut
twice
appli
fresh
report
cell
measur
ifn
biolog
activ
isreluciferas
report
gene
shown
fig
strongli
amplifi
ifn
activ
cultur
supernat
ssrnatransfect
cell
notic
supernat
cell
treat
alon
show
ifn
activ
line
previou
report
use
pyrimidin
biosynthesi
inhibitor
document
consequ
treatment
cellular
respons
ssrna
mrna
level
rigi
oligoadenyl
synthaselik
protein
oasl
determin
revers
transcriptionquantit
pcr
rtqpcr
result
show
respons
ssrna
transfect
amplifi
induct
rigi
oasl
fig
furthermor
effect
express
gene
could
revers
addit
uridin
cultur
medium
demonstr
pyrimidin
deplet
respons
amplifi
respons
ssrna
agreement
previou
report
confirm
result
protein
level
determin
rigi
express
western
blot
shown
fig
promot
express
rigi
cell
transfect
ssrna
parallel
measur
cultur
supernat
concentr
interferoninduc
protein
kda
wellcharacter
ifninduc
chemokin
fig
found
also
increas
express
cell
stimul
ssrna
altogeth
result
show
amplifi
express
isg
cell
stimul
ssrna
also
produc
higher
level
type
iii
ifn
illustr
origin
mechan
cell
commun
neighbor
metabol
statu
final
determin
also
amplifi
express
rigi
context
viral
infect
cell
infect
mv
moi
incub
h
let
viru
trigger
innat
immun
respons
dmso
alon
ad
addit
incub
period
h
quantifi
cultur
supernat
fig
wherea
rigi
express
level
determin
western
blot
cellular
pellet
fig
shown
fig
mv
alon
induc
differ
cytokin
effici
increas
express
express
rigi
mvinfect
cell
also
boost
presenc
surprisingli
express
mvinfect
cell
statist
enhanc
treatment
fig
contrast
result
obtain
ssrna
fig
effect
express
also
limit
even
though
observ
signific
induct
mv
plu
mv
infect
alon
one
explan
mv
encod
virul
factor
interfer
innat
immun
respons
particular
v
protein
bind
directli
prevent
activ
counteract
express
nevertheless
result
obtain
rigi
clearli
demonstr
boost
innat
immun
respons
virusinfect
cell
particular
express
type
iii
ifn
produc
high
level
system
compon
de
novo
pyrimidin
biosynthesi
pathway
dhodh
particular
becom
drug
target
prime
interest
treatment
multipl
patholog
includ
viral
microbi
infect
cancer
autoimmun
diseas
recent
exampl
breakthrough
studi
show
therapeut
potenti
dhodh
inhibitor
treatment
acut
myeloid
leukemia
far
teriflunomid
prodrug
leflunomid
use
immunosuppressor
treatment
multipl
sclerosi
rheumatoid
arthriti
two
dhodh
inhibitor
market
fig
howev
shown
immunosuppress
properti
drug
capac
inhibit
lymphocyt
prolifer
vivo
reli
interact
secondari
target
particular
tyrosin
kinas
therefor
identif
highli
activ
specif
inhibitor
de
novo
pyrimidin
biosynthesi
field
intens
competit
last
decad
mani
lead
compound
mostli
target
dhodh
character
detail
current
differ
stage
develop
howev
molecul
total
rna
extract
cellular
pellet
collect
h
express
level
specifi
gene
determin
rtqpcr
data
repres
mean
sd
result
independ
experi
bold
figur
correspond
statist
signific
differ
compar
dmsotreat
sampl
uridin
alon
p
calcul
twoway
anova
bonferroni
post
hoc
test
b
rigi
express
level
determin
western
blot
total
protein
extract
cell
h
upper
imag
correspond
repres
experi
graph
correspond
quantif
western
blot
result
valu
normal
actin
mean
sd
result
independ
experi
cell
transfect
ng
ssrna
p
p
calcul
oneway
anova
bonferroni
post
hoc
test
c
experi
total
concentr
indic
cytokin
cultur
supernat
h
determin
use
legendplex
analysi
kit
cell
transfect
ng
ssrna
data
repres
mean
sd
result
independ
experi
p
p
calcul
twotail
standard
test
cluster
rel
limit
number
chemic
famili
still
great
need
origin
structur
could
help
develop
molecul
suitabl
clinic
studi
describ
new
class
pyrimidin
biosynthesi
inhibitor
base
complement
experi
cellbas
assay
strongli
suggest
relat
analog
target
dhodh
requir
confirm
crystallographi
enzymat
studi
previous
determin
antivir
potenc
brequinar
teriflunomid
cell
infect
mvluc
ic
estim
nm
respect
fig
therefor
antivir
potenc
assay
compar
teriflunomid
much
lower
brequinar
dhodh
inhibitor
seri
pyrimidin
recent
describ
ic
nm
accordingli
brequinar
induc
isreluciferas
report
gene
cell
inhibit
de
novo
pyrimidin
biosynthesi
submicromolar
concentr
fig
b
thu
test
analog
clearli
among
activ
dhdoh
inhibitor
interest
lie
chemic
structur
inde
compound
devoid
carboxyl
group
character
dhodh
inhibitor
brequinar
famili
also
miss
amid
group
central
teriflunomid
deriv
fig
furthermor
novel
chemic
seri
describ
herein
base
two
edgefus
polycycl
moieti
link
togeth
someth
rel
uniqu
among
pyrimidin
biosynthesi
inhibitor
describ
literatur
knowledg
known
dhodh
inhibitor
form
two
edgefus
polycycl
moieti
dicoumarol
ic
test
recombin
enzym
descript
activ
limit
effect
innat
immun
viral
growth
report
fig
thu
test
dicoumarol
differ
assay
found
induc
isreluciferas
report
gene
cell
fig
amplifi
cellular
respons
ssrna
transfect
fig
effici
inhibit
mv
replic
ic
fig
importantli
despit
fact
dicoumarol
multipl
cellular
target
biolog
activ
antivir
effect
fulli
revers
supplement
cultur
medium
uridin
fig
thu
establish
function
link
inhibit
pyrimidin
biosynthesi
quit
interestingli
group
dicoumarol
show
obviou
similar
dihydrofurochromenon
molecular
dock
experi
dhodh
structur
also
suggest
regard
substitut
acid
brequinar
ensur
critic
interact
dhodh
thu
tempt
specul
moieti
activ
analog
play
role
altogeth
find
expand
current
knowledg
chemic
possibl
target
pyrimidin
biosynthesi
pathway
help
develop
drug
amen
clinic
importantli
character
detail
interact
new
seri
pyrimidin
biosynthesi
inhibitor
identifi
isreluciferas
screen
innat
antivir
respons
previous
shown
pyrimidin
biosynthesi
inhibitor
weak
stimul
isg
appli
alon
drug
boost
express
isg
respons
either
extracellular
intracellular
stimuli
rigi
ligand
virus
besid
pyrimidin
biosynthesi
inhibitor
induc
type
ifn
appli
alon
viru
growth
inhibit
drug
seem
occur
independ
synthesi
despit
recent
report
show
antivir
effect
vero
cell
delet
gene
cluster
show
synthes
induc
transfect
rna
antimicrobi
agent
chemotherapi
molecul
significantli
amplifi
cell
mvinfect
cell
also
increas
express
produc
high
level
system
note
cell
infect
h
addit
thu
allow
accumul
viral
rna
necessari
trigger
innat
immun
respons
antivir
state
settl
alway
perform
previou
report
might
account
contradictori
result
obtain
other
new
observ
challeng
idea
antivir
state
induc
pyrimidin
depriv
essenti
ifn
independ
inde
previous
report
chemic
inhibitor
signal
downstream
type
ii
iii
ifn
receptor
revers
antivir
state
induc
pyrimidin
biosynthesi
inhibitor
result
rather
expand
impact
pyrimidin
depriv
innat
antivir
respons
document
consequ
cytokin
secret
celltocel
commun
inde
show
cell
depriv
pyrimidin
suffer
metabol
stress
alarm
signal
send
neighbor
cell
respons
rigi
ligand
enhanc
quit
interestingli
link
cellular
metabol
cytokin
exchang
celltocel
commun
context
innat
immun
howev
way
pyrimidin
biosynthesi
inhibitor
influenc
express
innat
immun
gene
remain
pend
question
although
clearli
consequ
pyrimidin
depriv
sinc
abolish
cultur
medium
supplement
uridin
mechan
involv
still
poorli
understood
recent
shown
vero
cell
rigi
among
isg
induc
pyrimidin
biosynthesi
inhibitor
could
account
enhanc
sens
rna
howev
confirm
observ
cell
fig
b
suggest
rigi
induct
pyrimidin
biosynthesi
inhibitor
alon
cell
type
depend
futur
major
challeng
identifi
factor
sens
intracellular
level
pyrimidin
signal
pathway
trigger
induc
antivir
state
promot
express
isg
enhanc
synthesi
ifn
compound
librari
screen
procedur
analog
initi
screen
allow
identif
describ
detail
elsewher
briefli
cell
transfect
pisreluciferas
report
plasmid
refer
stratagen
dispens
cellswel
white
plate
alreadi
contain
l
compound
institut
curi
librari
mgml
dmso
sinc
final
cultur
volum
lwell
compound
screen
gml
correspond
compound
synthesi
describ
supplement
materi
tabl
cell
line
cultur
medium
luciferas
assay
cell
cultur
co
dulbecco
modifi
eagl
medium
dmem
gibcoinvitrogen
contain
fetal
calf
serum
fc
penicillin
streptomycin
human
cell
atcc
report
cell
line
correspond
cell
stabli
transfect
isreluciferas
report
gene
previous
describ
luciferas
induct
cell
determin
use
brightglo
promega
britelit
plu
reagent
perkinelm
accord
manufactur
recommend
bioluminesc
measur
luminomet
enspir
perkinelm
cellular
viabil
determin
quantif
atp
cultur
well
use
celltiterglo
assay
promega
virus
infect
immunostain
experi
measl
viru
mv
perform
vaccin
strain
schwarz
atcc
recombin
mv
strain
express
firefli
luciferas
mvluc
addit
transcript
unit
deriv
vaccin
strain
schwarz
previous
describ
viru
stock
produc
vero
cell
titrat
tissu
cultur
infect
dose
tcid
vero
cell
chikungunya
viru
chikv
infect
perform
wildtyp
strain
la
island
recombin
strain
chikvren
express
renilla
luciferas
kindli
provid
philipp
origin
obtain
atcc
viru
stock
produc
cell
previous
describ
firefli
renilla
luciferas
express
mvluc
chikvren
recombin
virus
determin
use
brightglo
promega
renillaglo
promega
reagent
respect
immunofluoresc
detect
viral
protein
cell
infect
chikv
moi
cultur
microscopi
slide
ibidi
munich
germani
h
postinfect
cell
fix
min
paraformaldehyd
pfa
permeabil
min
phosphatebuff
salin
pb
contain
triton
cell
incub
h
pb
supplement
goat
serum
incub
solut
contain
antibodi
chikv
protein
clone
kindli
provid
philipp
cell
infect
moi
cultur
microscopi
slide
ibidi
h
cell
fix
permeabil
describ
stain
antispik
glycoprotein
monoclon
antibodi
aldrich
clone
catalog
secondari
antimous
antirabbit
horseradish
peroxidas
hrp
conjug
antibodi
dako
catalog
sigmaaldrich
catalog
respect
protein
detect
perform
use
supersign
west
pico
chemiluminesc
substrat
thermo
fisher
scientif
quantifi
adob
photoshop
softwar
cytokin
quantif
cultur
supernat
cytokin
level
cultur
supernat
cell
stimul
ssrna
mv
without
dmso
determin
use
legendplex
analysi
kit
accord
manufactur
recommend
human
antiviru
respons
panel
vbottom
plate
catalog
supplement
materi
articl
may
found
http
supplement
file
pdf
file
mb
